Trial Profile
ZD4522 [Rosuvastatin; Crestor] Long Term Extension Trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Nov 2009
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Hypercholesterolaemia
- Focus Adverse reactions
- Sponsors AstraZeneca
- 29 Apr 2008 The expected completion date for this trial is now .
- 18 Apr 2008 New trial record.